Loading...
Header Logo
Keywords
Last Name
Institution

Dr Michael Musakiriza Makanga

Title[no position]
Institution[no institution name]
Address[no address]
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Breugelmans JG, Makanga MM, Cardoso AL, Mathewson SB, Sheridan-Jones BR, Gurney KA, Mgone CS. Bibliometric Assessment of European and Sub-Saharan African Research Output on Poverty-Related and Neglected Infectious Diseases from 2003 to 2011. PLoS Negl Trop Dis. 2015 Aug; 9(8):e0003997. PMID: 26262756.
      View in: PubMed
    2. Djimde AA, Makanga M, Kuhen K, Hamed K. The emerging threat of artemisinin resistance in malaria: focus on artemether-lumefantrine. Expert Rev Anti Infect Ther. 2015 Aug; 13(8):1031-45. PMID: 26081265.
      View in: PubMed
    3. Zumla A, Makanga M, Nyirenda T, Beattie P, Olesen OF, Breugelmans JG, Aklillu E, Corrah T, Mgone C. Genesis of EDCTP2. Lancet Infect Dis. 2015 Jan; 15(1):11-3. PMID: 25477021.
      View in: PubMed
    4. Makanga M. A review of the effects of artemether-lumefantrine on gametocyte carriage and disease transmission. Malar J. 2014 Jul 28; 13:291. PMID: 25069530.
      View in: PubMed
    5. Makanga M, Bassat Q, Falade CO, Premji ZG, Krudsood S, Hunt P, Walter V, Beck HP, Marrast AC, Cousin M, Rosenthal PJ. Efficacy and safety of artemether-lumefantrine in the treatment of acute, uncomplicated Plasmodium falciparum malaria: a pooled analysis. Am J Trop Med Hyg. 2011 Nov; 85(5):793-804. PMID: 22049029.
      View in: PubMed
    6. Kern SE, Tiono AB, Makanga M, Gbadoé AD, Premji Z, Gaye O, Sagara I, Ubben D, Cousin M, Oladiran F, Sander O, Ogutu B. Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis. Malar J. 2011 Jul 29; 10:210. PMID: 21801345.
      View in: PubMed
    7. Mgone C, Volmink J, Coles D, Makanga M, Jaffar S, Sewankambo N. Linking research and development to strengthen health systems in Africa. Trop Med Int Health. 2010 Dec; 15(12):1404-6. PMID: 20955373.
      View in: PubMed
    8. Mgone CS, Makanga M. Fighting HIV/AIDS, tuberculosis and malaria: one world, one partnership. Trop Med Int Health. 2010 Aug; 15(8):973-4. PMID: 20545926.
      View in: PubMed
    9. Ogutu B, Tiono AB, Makanga M, Premji Z, Gbadoé AD, Ubben D, Marrast AC, Gaye O. Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria? Malar J. 2010 Jan 22; 9:30. PMID: 20096111.
      View in: PubMed
    10. Makanga M, Krudsood S. The clinical efficacy of artemether/lumefantrine (Coartem). Malar J. 2009 Oct 12; 8 Suppl 1:S5. PMID: 19818172.
      View in: PubMed
    11. Matee MI, Manyando C, Ndumbe PM, Corrah T, Jaoko WG, Kitua AY, Ambene HP, Ndounga M, Zijenah L, Ofori-Adjei D, Agwale S, Shongwe S, Nyirenda T, Makanga M. European and Developing Countries Clinical Trials Partnership (EDCTP): the path towards a true partnership. BMC Public Health. 2009 Jul 20; 9:249. PMID: 19619283.
      View in: PubMed
    12. Kitua AY, Corrah T, Herbst K, Nyirenda T, Agwale S, Makanga M, Mgone CS. Strengthening capacity, collaboration and quality of clinical research in Africa: EDCTP Networks of Excellence. Tanzan J Health Res. 2009 Jan; 11(1):51-4. PMID: 19445106.
      View in: PubMed
    13. Makanga M, Premji Z, Falade C, Karbwang J, Mueller EA, Andriano K, Hunt P, De Palacios PI. Efficacy and safety of the six-dose regimen of artemether-lumefantrine in pediatrics with uncomplicated Plasmodium falciparum malaria: a pooled analysis of individual patient data. Am J Trop Med Hyg. 2006 Jun; 74(6):991-8. PMID: 16760509.
      View in: PubMed
    14. Falade C, Makanga M, Premji Z, Ortmann CE, Stockmeyer M, de Palacios PI. Efficacy and safety of artemether-lumefantrine (Coartem) tablets (six-dose regimen) in African infants and children with acute, uncomplicated falciparum malaria. Trans R Soc Trop Med Hyg. 2005 Jun; 99(6):459-67. PMID: 15837358.
      View in: PubMed
    15. Makanga M, Bray PG, Horrocks P, Ward SA. Towards a proteomic definition of CoArtem action in Plasmodium falciparum malaria. Proteomics. 2005 May; 5(7):1849-58. PMID: 15832369.
      View in: PubMed
    16. Maitland K, Makanga M, Williams TN. Falciparum malaria: current therapeutic challenges. Curr Opin Infect Dis. 2004 Oct; 17(5):405-12. PMID: 15353959.
      View in: PubMed
    17. Attaran A, Barnes KI, Curtis C, d'Alessandro U, Fanello CI, Galinski MR, Kokwaro G, Looareesuwan S, Makanga M, Mutabingwa TK, Talisuna A, Trape JF, Watkins WM. WHO, the Global Fund, and medical malpractice in malaria treatment. Lancet. 2004 Jan 17; 363(9404):237-40. PMID: 14738799.
      View in: PubMed
    18. Legros D, Johnson K, Houpikian P, Makanga M, Kabakyenga JK, Talisuna AO, Taylor WR. Clinical efficacy of chloroquine or sulfadoxine-pyrimethamine in children under five from south-western Uganda with uncomplicated falciparum malaria. Trans R Soc Trop Med Hyg. 2002 Mar-Apr; 96(2):199-201. PMID: 12055815.
      View in: PubMed
    Makanga's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description